The survival of patients with alcohol-related liver disease who receive a liver transplant has
steadily improved to reach 80–85% at 1 year post-transplantation. The standard requirement …

This review describes and discusses studies related to reduced-risk drinking as an
additional treatment option for patients with problematic alcohol use and alcohol …

BACKGROUND: There is a large treatment gap in alcohol dependence, and current
treatments are only moderately effective in preventing relapse. New treatment modalities …

This study evaluated the efficacy of as-needed use of the opioid system modulator
nalmefene in reducing alcohol consumption in patients with alcohol dependence. Seven …

Would you like to include more high interest cases in your Abnormal Psychology course?
Most textbooks on abnormal psychology include short descriptions of actual clinical cases …

Funding: This work was supported by an unrestricted contract from Lundbeck A/S. In
addition, WHO European Region supported the calculations of alcohol-attributable harm; …

Background Alcohol use disorder (AUD) is a highly prevalent public health problem
associated with considerable individual and societal costs. Abstinence from alcohol is the …

Identification of new medications for alcohol use disorder (AUD) is important for improving
treatment options. Baclofen, a GABAB agonist, has been identified as a potential …

This study evaluated the long-term efficacy and safety of nalmefene treatment in reducing
alcohol consumption. We randomised (1: 3) 675 alcohol-dependent patients≥ 18 years of …

Summary Background The latest French good practice recommendations (GPR s) for the
screening, prevention, and treatment of alcohol misuse were recently published in …